Calvenza EIV/EHV 2 ml/Dose 20 ml
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and by equine influenza virus types A2 North American and A2 Eurasian.
Product Details
| Approved For | Horse |
| Therapeutic Use | Vaccine |
| Form | Suspension |
| Route of Administration | May differ per dose |
| Strength / Concentration | 2 ml/Dose ml/Dose |
| Pack Size | 20 ml |
Safety & Storage
Storage: Refrigerated
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Boehringer Ingelheim |
|---|---|
| Strength | 2 ml/Dose ml/Dose |
| Pack Size | 20 ml |
Storage & Shipping
| Shipping Weight | 0.036 kg |
|---|---|
| Storage Conditions | Refrigerated |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.